Evidence map›Paper›PMID 40842484›Full record

ArticleNature machine intelligence2025

Histopathology-based protein multiplex generation using deep learning.

Sonali Andani, Boqi Chen, Joanna Ficek-Pascual, Simon Heinke, Ruben Casanova, Bernard Friedrich Hild, Bettina Sobottka, Bernd Bodenmiller, Tumor Profiler Consortium, Viktor H Koelzer and 1 more

Abstract read
In one paragraph

Article in Nature machine intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sonali Andani *Department of Computer Science, ETH Zurich, Zurich, Switzerland.
Boqi Chen *Department of Computer Science, ETH Zurich, Zurich, Switzerland.
Joanna Ficek-PascualDepartment of Computer Science, ETH Zurich, Zurich, Switzerland.
Simon HeinkeDepartment of Computer Science, ETH Zurich, Zurich, Switzerland.
Ruben CasanovaDepartment of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Bernard Friedrich HildDepartment of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Bettina SobottkaDepartment of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Bernd BodenmillerDepartment of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Tumor Profiler Consortium
Viktor H KoelzerComputational and Translational Pathology Group, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.ORCID 0000-0001-9206-4885
Gunnar RätschDepartment of Computer Science, ETH Zurich, Zurich, Switzerland.ORCID 0000-0001-5486-8532

Funding

Single-Cell Analyses of Human Islets in T1D Using Highly Multiplexed ImagingUC4DK108132 · NIDDK · UNIVERSITY OF FLORIDA · PI ATKINSON, MARK A., BODENMILLER, BERND · 2015 to 2015
$3.6M
NIDDK NIH HHS UC4 DK108132
6 · The paper itself

Abstract

Multiplexed protein imaging offers valuable insights into interactions between tumours and their surrounding tumour microenvironment, but its widespread use is limited by cost, time and tissue availability. Here we present HistoPlexer, a deep learning framework that generates spatially resolved protein multiplexes directly from standard haematoxylin and eosin (H&E) histopathology images. HistoPlexer jointly predicts multiple tumour and immune markers using a conditional generative adversarial architecture with custom loss functions designed to ensure pixel- and embedding-level similarity while mitigating slice-to-slice variations. A comprehensive evaluation of metastatic melanoma samples demonstrates that HistoPlexer-generated protein maps closely resemble real maps, as validated by expert assessment. They preserve crucial biological relationships by capturing spatial co-localization patterns among proteins. The spatial distribution of immune infiltration from HistoPlexer-generated protein multiplex enables stratification of tumours into immune subtypes. In an independent cohort, integration of HistoPlexer-derived features into predictive models enhances performance in survival prediction and immune subtype classification compared to models using H&E features alone. To assess broader applicability, we benchmarked HistoPlexer on publicly available pixel-aligned datasets from different cancer types. In all settings, HistoPlexer consistently outperformed baseline methods, demonstrating robustness across diverse tissue types and imaging conditions. By enabling whole-slide protein multiplex generation from routine H&E images, HistoPlexer offers a cost- and time-efficient approach to tumour microenvironment characterization with strong potential to advance precision oncology.

Indexed as

Computational modelsMachine learningMelanoma

Identifiers

PMID40842484
PMCPMC12364712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.